AlphaMet, formerly CyclaPlex, develops, manufactures, and markets the "CyclaPlex Correction System", an implant device designed to prevent bone osteotomy, shorten recovery time, reduce pain, and help patients get back to normal within days of undergoing bunion surgery. CyclaPlex is FDA cleared for use by surgeons and is distributed in the U.S. by Genesis Ortho Partners.